Let's say for the sake of argument that we are equ
Post# of 148281
Obviously I would rather have all of the market share. But I keep coming back to the fact that we need revenue so we can unlock the full potential of this molecule.
That's the big prize. COVID and HIV are the means to the end for Leronlimab. A way to get to the true potential.
So, what we need is SOME revenue. Not ALL of the revenue. Please keep this in mind.